Herpes Simplex Virus Vectors Enable Persistent Transgene Expression in Motor Neurons

Researchers have successfully characterized the features of herpes simplex virus-1 (HSV)-derived vectors, enabling efficient transduction of motor neurons in a relatively noninvasive manner. The study, conducted by M.C.P. Perez and colleagues from BioVex Ltd., utilized viral vectors with differing degrees of disablement to achieve prolonged gene expression in motor neurons. The findings demonstrate the potential of HSV vectors for persistent transgene expression in motor neurons, providing a valuable tool for investigating gene functions involved in motor neuronal survival and regeneration in models of motor neuron diseases.

Key Takeaways:

• The study utilized herpes simplex virus-1 (HSV)-derived vectors for gene delivery to motor neurons in vivo, achieving efficient transduction with relative noninvasiveness.
• The researchers characterized the features of HSV-derived vectors, including gene mutations and promoter constructs, to enable efficient transduction of motor neurons.
• The use of viral vectors with differing degrees of disablement, including the deletion of essential genes ICP27 and/or ICP4, demonstrated the feasibility of HSV vectors for persistent transgene expression in motor neurons.
• The study demonstrated the potential of HSV vectors for prolonged gene expression in motor neurons, with sustained expression observed in mice and rats following peripheral administration.
• The vectors were found to be safe and nontoxic, offering a valuable tool for investigating gene functions involved in motor neuronal survival and regeneration in models of motor neuron diseases.

The researchers used viruses with differing degrees of disablement based on the 1764 backbone, which included the deletion of ICP34.5, ICP27, and/or ICP4. The study found that the vector defective in ICP4 and ICP27 was capable of transducing motor neurons for extended periods of time during viral latency.

Statistics:

• The study utilized adult mice and adult and neonatal rats as models for experimental gene therapy.
• The researchers demonstrated prolonged gene expression in motor neurons up to 1023-1032 days in adult mice and 103 days in adult rats following peripheral administration.
• The study found that HSV vectors were capable of transducing motor neurons for extended periods of time during viral latency, with sustained expression observed in both mice and rats.

Sources:

• Perez, M.C.P., and colleagues. "Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo." Gene Therapy, 2004;11(13):1023-1032.
• BioVex Ltd. Windeyer Institute of Medical Science. 46 Cleveland St., London W1T 4JF, England.
• Nature Publishing Group. Macmillan Building, 4 Crinan St., London N1 9XW, England.